BROOMFIELD, Colo., March 3, 2020 /PRNewswire/ -- Intelivideo, a Video On Demand (VOD) technology platform headquartered

LUND, Sweden and STRASBOURG, France , March 3, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext Paris: TNG), a biotech c

WALTHAM, Mass. and VENLO, Netherlands, March 3, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of molecular diagnostics and sample preparation technologies, today announced that their boards of

GOTHENBURG, Sweden, March 3, 2020 /PRNewswire/ -- Richard Twomey, President and CEO of Mölnlycke, will after six years leave the organisation."Richard has with his deep knowledge and experience within the medical technology industry developed Mölnlycke into an even stronger company in its field. During his time the c

STOCKHOLM, March 3, 2020 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company's partner Eisai will include Swedish clinics in the confirmatory Phase 3 study of the drug candidate BAN2401. The enrollment of patients with early Alzheimer's disease will be carried out at memory clinics at four Swedish university hosp

OSLO, Norway, March 3, 2020 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces that it has completed patient enrollment in the phase I trial with ONCOS-102 in combination with Keytruda (pembrolizumab) in patients with advanced anti-PD1 checkpoint

WASHINGTON, March 3, 2020 /PRNewswire/ -- U.S. News & World Report, the global authority in rankings and

VANCOUVER, March 2, 2020 /PRNewswire/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQX: HRVOF) today announced its financial and operating results for the three and six months ended December 31, 2019, as well as an update on the Company's strategic plan.

NORTH CHICAGO, Ill., March 2, 2020 /PRNewswire/ -- AbbVie issued the following forms today.IRISH TAKEOVER PANEL

SILVER SPRING, Md., March 2, 2020 /PRNewswire/ -- Today, in a joint effort, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention took action to make more respirators, including certain N95s, available to health care personnel. Currently, the majority of respirators on the market are indicated for use in industrial settings. Today's act